CRP and Hypoalbuminemia: Inflammation-related biomarkers, such as albumin and C-reactive protein (CRP), have been identified as prognostic indicators in RCC, with hypoalbuminemia and elevated CRP levels consistently associated with poor clinical outcomes [11–13].